The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Berenberg Bank analyst Kerry Holford maintained a Hold rating on Hochschild Mining (HOC – Research Report) yesterday and set a price target of ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

(Bloomberg) -- Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne ...

The High Court ruled on a significant patent dispute involving Pfizer and GSK, addressing costs and confidentiality.

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Pfizer is looking to sell about 700 million ordinary shares in Haleon , its bookrunner J.P. Morgan said on Tuesday, lowering ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

Pfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 ...